文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

瑞士药品标签中的药物遗传学信息——系统分析。

Pharmacogenetic information in Swiss drug labels - a systematic analysis.

机构信息

Pharmaceutical Care Research Group, Department of Pharmaceutical Sciences, University of Basel, Basel, 4001, Switzerland.

European Center of Pharmaceutical Medicine, Faculty of Medicine, University of Basel, Basel, 4056, Switzerland.

出版信息

Pharmacogenomics J. 2021 Aug;21(4):423-434. doi: 10.1038/s41397-020-00195-4. Epub 2020 Oct 17.

DOI:10.1038/s41397-020-00195-4
PMID:33070160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8292148/
Abstract

Implementation of pharmacogenetics (PGx) and individualization of drug therapy is supposed to obviate adverse drug reactions or therapy failure. Health care professionals (HCPs) use drug labels (DLs) as reliable information about drugs. We analyzed the Swiss DLs to give an overview on the currently available PGx instructions. We screened 4306 DLs applying natural language processing focusing on drug metabolism (pharmacokinetics) and we assigned PGx levels following the classification system of PharmGKB. From 5979 hits, 2564 were classified as PGx-relevant affecting 167 substances. 55% (n = 93) were classified as "actionable PGx". Frequently, PGx information appeared in the pharmacokinetics section and in DLs of the anatomic group "nervous system". Unstandardized wording, appearance of PGx information in different sections and unclear instructions challenge HCPs to identify and interpret PGx information and translate it into practice. HCPs need harmonization and standardization of PGx information in DLs to personalize drug therapies and tailor pharmaceutical care.

摘要

实施药物遗传学（PGx）并个体化药物治疗，旨在避免药物不良反应或治疗失败。医疗保健专业人员（HCPs）将药品标签（DLs）用作有关药物的可靠信息。我们分析了瑞士的 DLs，以概述当前可用的 PGx 说明。我们应用自然语言处理筛选了 4306 个 DLs，重点关注药物代谢（药代动力学），并根据 PharmGKB 的分类系统分配 PGx 水平。在 5979 个命中中，有 2564 个被归类为与 PGx 相关，影响 167 种物质。其中 55%（n=93）被归类为“可操作的 PGx”。PGx 信息经常出现在药代动力学部分和“神经系统”解剖组的 DLs 中。非标准化的措辞、PGx 信息出现在不同部分以及不明确的说明，使 HCPs 在识别和解释 PGx 信息并将其转化为实践方面面临挑战。HCPs 需要在 DLs 中对 PGx 信息进行协调和标准化，以实现药物治疗的个体化和定制药物护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/4fa56312f73a/41397_2020_195_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/c8ce72eaa632/41397_2020_195_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/18209757e9bb/41397_2020_195_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/8ef68566bf8f/41397_2020_195_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/c71ddcf0a7ee/41397_2020_195_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/71fb1ca4d3b0/41397_2020_195_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/4fa56312f73a/41397_2020_195_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/c8ce72eaa632/41397_2020_195_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/18209757e9bb/41397_2020_195_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/8ef68566bf8f/41397_2020_195_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/c71ddcf0a7ee/41397_2020_195_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/71fb1ca4d3b0/41397_2020_195_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e60b/8292148/4fa56312f73a/41397_2020_195_Fig6_HTML.jpg

相似文献

[1]
Pharmacogenetic information in Swiss drug labels - a systematic analysis.

Pharmacogenomics J. 2021-8

[2]
Implementation of pharmacogenomics in product information.

Pharmacogenomics. 2020-5

[3]
Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.

J Clin Pharm Ther. 2018-8

[4]
Pharmacogenomic biomarkers in drug labels: what do they tell us?

Pharmacogenomics. 2014-2

[5]
Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies.

Pharmacogenomics J. 2024-1-17

[6]
Pharmacogenomic information in drug labels: European Medicines Agency perspective.

Pharmacogenomics J. 2015-6

[7]
Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.

Am J Health Syst Pharm. 2022-6-7

[8]
ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.

Medicines (Basel). 2024-2-20

[9]
Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.

Expert Opin Drug Metab Toxicol. 2019-9-12

[10]
Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.

Pharmacogenomics. 2023-6

引用本文的文献

[1]
Pharmacogenetic Information on Drug Labels of the Italian Agency of Medicines (AIFA): Actionability and Comparison Across Other Regulatory Agencies.

Clin Transl Sci. 2025-2

[2]
Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice.

Genes (Basel). 2024-7-1

[3]
Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study.

Pharmgenomics Pers Med. 2023-7-3

[4]
Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.

Int J Clin Pharm. 2023-12

[5]
Knowledge and attitudes of medical and pharmacy students about pharmacogenomics: a systematic review and meta-analysis.

Pharmacogenomics J. 2023-9

[6]
Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database.

Pharmgenomics Pers Med. 2022-11-23

[7]
A bibliometric analysis of global trends in the research field of pharmaceutical care over the past 20 years.

Front Public Health. 2022

[8]
A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting.

Pharmacy (Basel). 2022-7-19

[9]
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report.

Pharmgenomics Pers Med. 2022-5-9

[10]
Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.

Trials. 2021-12-14

本文引用的文献

[1]
Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.

Genet Med. 2019-3-30

[2]
The association between the SLCO1B1, apolipoprotein E, and CYP2C9 genes and lipid response to fluvastatin: a meta-analysis.

Pharmacogenet Genomics. 2018-12

[3]
Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.

J Clin Pharm Ther. 2018-8

[4]
CYP2D6 drug-gene and drug-drug-gene interactions among patients prescribed pharmacogenetically actionable opioids.

Appl Nurs Res. 2017-12

[5]
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.

Neurology. 2017-1-3

[6]
Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions.

Front Pharmacol. 2016-10-21

[7]
Prediction of CYP2D6 phenotype from genotype across world populations.

Genet Med. 2017-1

[8]
Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.

Pharmacogenomics J. 2017-12

[9]
Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.

Pharmacogenomics J. 2017-3

[10]
ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.

Am J Med Genet B Neuropsychiatr Genet. 2015-6

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索